Instrument Inactif

Communiqués Cytomedix, Inc. OTC Bulletin Board

Actions

CMXI

US23283B2043

Recherche biotechnologique et médicale

Cours en clôture OTC Bulletin Board
- ^USD	-

14/08	Nuo Therapeutics, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
14/05	Nuo Therapeutics, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Communiqués

17/08	Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update	AQ
14/05	Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update	AQ
17/04/25	Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies	AQ
26/06/23	Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange	AQ
22/06/23	Nuo Therapeutics’ Aurix® System Added To Wound Care Formulary Of Wound Care Advantage	AQ
17/04/23	NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
05/12/22	NUO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
04/11/22	NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
30/09/22	NUO THERAPEUTICS, INC. : Shareholder Director Nominations, Other Events (form 8-K)	AQ
30/08/22	Nuo Therapeutics Provides Corporate and Business Update	AQ
30/08/22	NUO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
10/08/22	Nuo Therapeutics : Amendment to Quarterly Report - Form 10-Q/A	PU
10/08/22	NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q/A)	AQ
08/08/22	NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
28/06/22	NUO THERAPEUTICS, INC. : Other Events (form 8-K)	AQ
16/05/22	NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
02/05/22	NUO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	AQ
15/04/22	NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
04/02/22	Nuo Therapeutics Responds to Mini-Tender Offer	GL
21/01/22	Alternative Liquidity Index Announces Offer to Purchase Shares in Nuo Therapeutics, Inc.	AQ
04/01/22	NUO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	AQ
21/04/21	NUO THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20/04/21	Nuo Therapeutics : Announces Publication of Final Decision Memo for Autologous Blood Derived Products for Chronic Non-Healing Wounds by Centers for Medicare & Medicaid Services	PR
06/10/20	NUO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	AQ
13/04/20	NUO THERAPEUTICS, INC. : Other Events (form 8-K)	AQ